Plus news about Alchemist Capital, Newron Pharmaceuticals, Life Biosciences, Onyx Bio and Tecentriq.
City Therapeutics charts $158M IPO: The RNAi startup, from former Alnylam Pharmaceuticals …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Source link







